NASDAQ:ERYP - ERYTECH Pharma S.A.
$7.59
 $-0.69
-8.33%
4:00PM EDT
2019-04-18
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ERYP     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 60   199. 07   233. 87  
42 stocks rank:  3. 75 K 1. 43 K 1. 06 K
# analyst opinions:  2. 00   14. 48   14. 09  

quick ratio:  6. 98   5. 29   1. 92  
current ratio:  7. 26   5. 64   2. 40  

target price low:  9. 57   84. 50   115. 74  
target price avg:  10. 05   110. 73   137. 39  
target price high:  10. 53   136. 41   157. 80  
1-yr high:  21. 41   114. 11   138. 85  
last close:  7. 59   87. 56   116. 78  
50-day avg:  8. 25   95. 43   123. 53  
200-day avg:  8. 66   94. 13   121. 20  
1-yr low:  5. 54   72. 67   98. 41  
volume:  2. 08 K 2. 43 M 4. 85 M
50-day avg volume:  2. 32 K 2. 72 M 4. 97 M
200-day avg volume:  2. 20 K 2. 90 M 4. 58 M

1-day return:  -7. 89 % -0. 40 % 0. 07 %
this week return:  0. 26 % -5. 72 % -4. 11 %
12-wk return:  -11. 45 % 1. 78 % -0. 04 %
52-wk return:  -63. 46 % 10. 81 % 14. 09 %

enterprise value (EV):  135. 79 M 51. 19 B 117. 96 B
market cap:  144. 61 M 43. 00 B 104. 52 B
debt/equity:  1. 39   46. 86   89. 46  

shares outstanding:  17. 94 M 570. 91 M 1. 24 B
shares:  10. 23 M 571. 02 M 1. 23 B
shares short:  2. 83 K 9. 93 M 16. 79 M
shares short prior month:  2. 95 K 9. 96 M 16. 58 M
short ratio:  1. 72   5. 31   3. 30  

book value:  10. 64   12. 76   26. 84  
price/book:  0. 71   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  100. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -28. 97 % --- ---
1-yr mean volatility:  -0. 29 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 79   2. 39   4. 08  
forward EPS:  -4. 30   3. 97   7. 14  
P/E:  -2. 72   13. 59   22. 83  
forward P/E:  -1. 76   -20. 05   14. 49  
PE/G:  -0. 01   -1. 46   1. 68  
growth:  263. 60 % 126. 81 % 29. 29 %
earnings high:  -0. 43   1. 02   1. 63  
earnings avg:  -0. 43   0. 76   1. 51  
earnings low:  -0. 43   0. 47   1. 39  
revenue high:  2. 40 M 2. 68 B 10. 71 B
revenue avg:  2. 40 M 2. 59 B 10. 49 B
revenue low:  2. 40 M 2. 49 B 10. 25 B
return on assets:  -15. 02 % -2. 80 % 5. 29 %
return on equity:  -23. 38 % -18. 52 % 7. 38 %
revenue growth:  263. 60 % 92. 55 % 19. 15 %

beta (1yr vs S&P500):  1. 19   1. 24   0. 93  
sharpe (1yr):  -0. 97   0. 29   0. 60  

held % insiders:  0. 39 % 6. 38 % 3. 38 %
held % institutions:  7. 77 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : ERYP
.        + 0 =             0 :: INITIAL WEIGHT
.   + 60.564 =        60.564 :: inverse volume-to-price addition
.   + 43.128 =       103.692 :: spline projection addition
.     x 1.01 =        104.71 :: 13 weeks' performance factor
.    x 0.609 =        63.736 :: one-year gains+dividend factor
.    x 1.432 =        91.271 :: industry recommendation factor
.    x 0.998 =        91.134 :: return on assets factor
.    x 0.998 =        90.921 :: return on equity factor
.    x 2.571 =       233.745 :: revenue growth factor
.    x 2.712 =       634.015 :: current ratio factor
.     x 1.08 =       685.002 :: quick ratio factor
.    x 1.258 =       861.414 :: short ratio factor
.    x 2.007 =      1728.974 :: price-to-book factor
.    x 1.015 =      1754.375 :: debt-to-equity factor
.     x 2.13 =      3736.748 :: P/E weight
.    x 2.209 =      8254.324 :: PE/G factor
.    x 1.464 =     12085.829 :: beta factor
.    x 0.968 =     11701.877 :: sharpe factor
.    x 1.532 =     17932.332 :: target low factor
.     x 1.19 =     21334.672 :: target mean factor
.    x 1.062 =     22661.702 :: target high factor
.    x 1.312 =     29724.184 :: industry 2-weeks return factor
.    x 0.956 =     28422.863 :: "drift" penalty 2 days ago
.    x 0.931 =     26449.984 :: "drift" penalty 3 days ago
.    x 0.959 =     25363.831 :: "drift" penalty 4 days ago
.    x 0.896 =     22731.172 :: "drift" penalty 5 days ago
.    x 0.984 =     22358.118 :: overall "drift" factor
.    x 0.998 =     22323.107 :: largest single-day jump factor
.    x 0.104 =      2327.748 :: low price factor
.      x 1.0 =      2327.373 :: factor hist industry gain for week 15
.   cubeRoot =        13.252 :: reduced to standardize
.   - 22.154 =           0.6 :: add/subtract for performance
.                        0.6 :: FINAL WEIGHT for NASDAQ:ERYP


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org